se comes back or becomes worse after treatment with two prior medicines, one of which included bortezomib. MCL is a cancer of a type of white blood cell called lymphocytes that are in the lymph nodes.
REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial.
It is not known if REVLIMID is safe and effective in children.
Who should not take REVLIMID?
Do not take REVLIMID if you:
are pregnant, plan to become pregnant, or become pregnant during treatment with REVLIMID. See “What is the most important information I should know about REVLIMID?”
are allergic to lenalidomide or any of the ingredients in REVLIMID. See the end of this Medication Guide for a complete list of ingredients in REVLIMID.
What should I tell my healthcare provider before taking REVLIMID?
Before you take REVLIMID, tell your healthcare provider about all of your medical conditions, including if you:
have liver problems
have kidney problems or receive kidney dialysis treatment
have thyroid problems
are lactose intolerant. REVLIMID contains lactose.
are breastfeeding. Do not breastfeed during treatment with REVLIMID. It is not known if REVLIMID passes into your breast milk and can harm your baby.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. REVLIMID and other medicines may affect each other, causing serious side effects. Talk with your healthcare provider before taking any new medicines.
Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist.
How should I take REVLIMID?
Take REVLIMID exactly as prescribed and follow all the instructions of the REVLIMID REMS program
Swallow REVLIMID capsules whole with water 1 time a day. Do not open, break, or chew your capsules.
REVLIMID may be taken with or without food.
Take REVLIMID at about the same time each day.
Do not open or break REVLIMID capsules or handle them any more than needed. If powder from the REVLIMID capsule comes in contact with your skin, wash the skin right away with soap and water.
If powder from the REVLIMID capsule comes in contact with the inside of your eyes, nose, or mouth, flush well with water.
If you miss a dose of REVLIMID and it has been less than 12 hours since your regular time, take it as soon as you remember. If it has been more than 12 hours, just skip your missed dose. Do not take 2 doses at the same time.
If you take too much REVLIMID, call your healthcare provider right away.
What should I avoid while taking REVLIMID?
See “What is the most important information I should know about REVLIMID?”
Females: Do not get pregnant and do not breastfeed while taking REVLIMID.
Males: Do not donate sperm.
Do not share REVLIMID with other people. It may cause birth defects and other serious problems.
Do not donate blood while you take REVLIMID, during any breaks (interruptions) in your treatment, and for 4 weeks after stopping REVLIMID. If someone who is pregnant gets your donated blood, her baby may be exposed to REVLIMID and may be born with birth defects.
What are the possible side effects of REVLIMID?
REVLIMID can cause serious side effects, including:
See “What is the most important information I should know about REVLIMID?”
Increased risk of death in people who have chronic lymp
